Drugs & medicalClass II

bioMerieux, Inc. recalls VIDAS RUB IgG (RBG), REF 30226

bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.

Read the official notice →
Date
2022-01-05
Country
United States
Brand
Biomerieux
Product
VIDAS RUB IgG (RBG), REF 30226
Classification
Class II
Units
US Nationwide distribution.
Category
Drugs & medical
Source
FDA · Device

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Biomerieux recalls

  1. 2022-08-31
  2. US
    Drugs & medicalClass II

    bioMerieux, Inc. recalls NUCLISENS easyMAG Magnetic Silica, REF 280133, 24 x 1.2mL bottles/kit.

    There is a potential of no result leading to possible delayed result due to contamination of extraction reagents.

    FDA · DevicebioMerieux, Inc.Distribution was made to AR, AZ, CA, CT, FL, IL, IN, KS, KY, MA, MD, MI, MN,…Official notice →
  3. 2022-05-18
  4. US
    Drugs & medicalClass II

    bioMerieux, Inc. recalls VITEK 2 Systems and VITEK 2 with MYLA.

    Software issue where results sent to the LIS via HL7 format for antibiotic screen tests and synergy tests do not include the user-corrected or AES-corrected interpretation. This can potentially lead to incorrect final…

    FDA · DevicebioMerieux, Inc.U.S. distribution of the FSCA to NC. OUS distribution of the FSCA to…Official notice →
  5. 2022-02-02
  6. US
    Drugs & medicalClass II

    Biomerieux Inc recalls API ID 32 C Strips, Reference 32200, Rx Only, IVD API ID 32 C is a qualitative standardized system for the identification of yeasts. It…

    Risk of misidentification or delayed results with the absence of identification due to thermoforming defect.

    FDA · DeviceBiomerieux IncUS (Domestic) Distribution to states of: AZ, IA, KY, and NY.Official notice →
  7. 2022-01-05
  8. US
    Drugs & medicalClass II

    Biomerieux Inc recalls RAPID 20 E, REF 20701, System for the identification of Enterobacteriaceae in 4 hours, 25 strips/package, IVD.

    There is an error in the new version of the package insert. The Reading Table lists the incorrect color for a negative result for the CIT test.

    FDA · DeviceBiomerieux IncUS Nationwide distribution in the states of AL, AZ, CA, CO, CT, DE, FL, GA,…Official notice →
  9. 2021-11-24
  10. US
    Drugs & medicalClass II

    bioMerieux, Inc. recalls API 50 CH, Model 50300

    There is potential to provide an incorrect organism identification.

    FDA · DevicebioMerieux, Inc.Distribution in WI, NY, and SDOfficial notice →
  11. 2021-10-20
  12. US
    Drugs & medicalClass II

    BioMerieux SA recalls MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO System

    Under certain conditions, there is a risk for a false negative result.

    FDA · DeviceBioMerieux SAWorldwide distribution - US Nationwide distribution and the countries of…Official notice →
All 16 Biomerieux recalls →

Other drugs & medical recalls in the United States

  1. 2022-01-05
  2. US
    Drugs & medicalClass II

    Karl Storz Endoscopy recalls Karl Storz Udel Sterilization Tray Instructions for Use, Tray Part Number/Description: 39301ACTS/CAMERA TRAY (STERRAD, INLINE CAMERA…

    To ensure sterilization effectiveness, sterilization tray instructions for use were updated and now state 1) udel trays may be used with flexible endoscopes with lumen diameters greater-than-or-equal to 1.2mm and…

    FDA · DeviceKarl Storz EndoscopyUS: AK, AL, AP, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS,…Official notice →
  3. US
    Drugs & medicalClass II

    Siemens Medical Solutions USA, Inc recalls ARTISTE with syngo RT Therapist-linear accelerator systems to deliver X-Ray photon and electron radiation for the therapeutic…

    Potential safety issue under specific preconditons that may result in a user selecting the wrong site for treatment with the possibility to deliver dose to the wrong isocenter which could result in serious patient injury

    FDA · DeviceSiemens Medical Solutions USA, IncUS Nationwide distribution in the states of IA, LA, NE, NJ, NV, NY, OH, PA,…Official notice →
  4. US
    Drugs & medicalClass II

    Siemens Healthcare Diagnostics, Inc. recalls Atellica CH ¿2-Microglobulin (B2M) -M) Assay for in vitro diagnostic use in the quantitative determination of…

    ¿2 Microglobulin (B2M) Reagent Lot 211446 Bias with Quality Control and Patient Sample Results. Positive bias on patient samples of up to +20.9% at a B2M concentration of approximately 1.5 mg/L and a negative bias on…

    FDA · DeviceSiemens Healthcare Diagnostics, Inc.Worldwide distribution - US Nationwide distribution in the states of CA, CO,…Official notice →
  5. US
    Drugs & medicalClass II

    Forbes Rehab Services Inc recalls Affected components are limited to the Monoprice charging cable (Product # 4867) and 24W iClever Boost Cube charging brick components…

    Warning Added: Using damaged cables or chargers, or charging when moisture is present, can cause fire, electric shock, injury, or damage to Speech Generating Device or other property

    FDA · DeviceForbes Rehab Services IncUS Nationwide distribution.Official notice →
  6. US
    Drugs & medicalClass II

    Biomerieux Inc recalls RAPID 20 E, REF 20701, System for the identification of Enterobacteriaceae in 4 hours, 25 strips/package, IVD.

    There is an error in the new version of the package insert. The Reading Table lists the incorrect color for a negative result for the CIT test.

    FDA · DeviceBiomerieux IncUS Nationwide distribution in the states of AL, AZ, CA, CO, CT, DE, FL, GA,…Official notice →
  7. US
    Drugs & medicalClass II

    Migo Trading LLC recalls FLOWFLEX SARS-COV-2 Antigen Rapid Test (Self-Testing), 1 Test

    Devices are determined to be inconsistent with the firm's Emergency Use Authorization (EUA). This product has not been authorized for emergency use and the test cannot be determined to be adequately validated for the…

    FDA · DeviceMigo Trading LLCNYOfficial notice →
See all drugs & medical recalls →